Role of Bone Morphogenetic Protein 2 Polymorphisms in Bone Mineral Density after the Start of Treatment with Atorvastatin.

Basic Clin Pharmacol Toxicol. 2018 Dec;123(6):766-769. doi:10.1111/bcpt.13086.

Usategui-Martín R, Vega G, Abad-Manteca L, Ruiz-Mambrilla M, Calero-Paniagua I, Dueñas-Laita A, Pérez-Castrillón JL.